Chemicals

N-BOC-4,4-difluoro-L-proline

We are N-BOC-4,4-difluoro-L-proline CAS:203866-15-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-BOC-4,4-difluoro-L-proline

CAS.NO:203866-15-3

Synonyms:N-t-BOC-4,4-Difluoro-L-Proline

(S)-1-(tert-Butoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid

(2S)-4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

4,4-Difluoro-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline

1-(tert-Butoxycarbonyl)-4,4-difluoro-L-proline

N-(tert-Butoxycarbonyl)-4,4-difluoro-L-proline

Molecular Formula:C10H15F2NO4

Molecular Weight:251.22700

Physical and Chemical Properties:

Density:1.31

Melting point:120-124ºC

Boiling point:340ºC

Index of Refraction:1.474

Specification:

Appearance:White solid

Assay:≥97.0%

Melting point:126-128ºC

Moisture:≤0.5%

Packing:25 kg/drum, can also be packaged according to customer requirements

Storage:Store in a cool, ventilated place

Application:N-Boc-4,4-difluoro-L-proline is a reagent used in the preparation of structure-activity relationship and pharmacokinetics of pyrrolotriazines as pan-Aurora kinase inhibitors and anti tumor agents.

N-BOC-4,4-difluoro-L-proline

Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide CAS:361440-68-8 A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.(4-metilfenil) metil tiocianato CAS:18991-39-4 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.477600-68-3 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.

Product Name
2-(2,5-Diaminophenyl)ethanol sulfate	View Details
N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine	View Details
2-Fluoro-5-methylaniline	View Details